Cargando…
The commercialization of university-based research: Balancing risks and benefits
BACKGROUND: The increasing push to commercialize university research has emerged as a significant science policy challenge. While the socio-economic benefits of increased and rapid research commercialization are often emphasized in policy statements and discussions, there is less mention or discussi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605102/ https://www.ncbi.nlm.nih.gov/pubmed/26464028 http://dx.doi.org/10.1186/s12910-015-0064-2 |
_version_ | 1782395166899830784 |
---|---|
author | Caulfield, Timothy Ogbogu, Ubaka |
author_facet | Caulfield, Timothy Ogbogu, Ubaka |
author_sort | Caulfield, Timothy |
collection | PubMed |
description | BACKGROUND: The increasing push to commercialize university research has emerged as a significant science policy challenge. While the socio-economic benefits of increased and rapid research commercialization are often emphasized in policy statements and discussions, there is less mention or discussion of potential risks. In this paper, we highlight such potential risks and call for a more balanced assessment of the commercialization ethos and trends. DISCUSSION: There is growing evidence that the pressure to commercialize is directly or indirectly associated with adverse impacts on the research environment, science hype, premature implementation or translation of research results, loss of public trust in the university research enterprise, research policy conflicts and confusion, and damage to the long-term contributions of university research. SUMMARY: The growing emphasis on commercialization of university research may be exerting unfounded pressure on researchers and misrepresenting scientific research realities, prospects and outcomes. While more research is needed to verify the potential risks outlined in this paper, policy discussions should, at a minimum, acknowledge them. |
format | Online Article Text |
id | pubmed-4605102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46051022015-10-15 The commercialization of university-based research: Balancing risks and benefits Caulfield, Timothy Ogbogu, Ubaka BMC Med Ethics Debate BACKGROUND: The increasing push to commercialize university research has emerged as a significant science policy challenge. While the socio-economic benefits of increased and rapid research commercialization are often emphasized in policy statements and discussions, there is less mention or discussion of potential risks. In this paper, we highlight such potential risks and call for a more balanced assessment of the commercialization ethos and trends. DISCUSSION: There is growing evidence that the pressure to commercialize is directly or indirectly associated with adverse impacts on the research environment, science hype, premature implementation or translation of research results, loss of public trust in the university research enterprise, research policy conflicts and confusion, and damage to the long-term contributions of university research. SUMMARY: The growing emphasis on commercialization of university research may be exerting unfounded pressure on researchers and misrepresenting scientific research realities, prospects and outcomes. While more research is needed to verify the potential risks outlined in this paper, policy discussions should, at a minimum, acknowledge them. BioMed Central 2015-10-14 /pmc/articles/PMC4605102/ /pubmed/26464028 http://dx.doi.org/10.1186/s12910-015-0064-2 Text en © Caulfield and Ogbogu. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Debate Caulfield, Timothy Ogbogu, Ubaka The commercialization of university-based research: Balancing risks and benefits |
title | The commercialization of university-based research: Balancing risks and benefits |
title_full | The commercialization of university-based research: Balancing risks and benefits |
title_fullStr | The commercialization of university-based research: Balancing risks and benefits |
title_full_unstemmed | The commercialization of university-based research: Balancing risks and benefits |
title_short | The commercialization of university-based research: Balancing risks and benefits |
title_sort | commercialization of university-based research: balancing risks and benefits |
topic | Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605102/ https://www.ncbi.nlm.nih.gov/pubmed/26464028 http://dx.doi.org/10.1186/s12910-015-0064-2 |
work_keys_str_mv | AT caulfieldtimothy thecommercializationofuniversitybasedresearchbalancingrisksandbenefits AT ogboguubaka thecommercializationofuniversitybasedresearchbalancingrisksandbenefits AT caulfieldtimothy commercializationofuniversitybasedresearchbalancingrisksandbenefits AT ogboguubaka commercializationofuniversitybasedresearchbalancingrisksandbenefits |